SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
IBO

Impact Biomedical Inc. (IBO)

NYSE: IBO · USD
Healthcare · Biotechnology
$6.17+$1.26 (+25.66%)
 
Market cap
$53.3M
Insider Score
Market Cap$53.31M
Revenue (ttm)$38.00K
Net Income$1.61M
EPS$12.57
Shares Out8.64M
PE Ratio0.49
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume25,181
Open$5.18
Previous Close$4.91
Day's Range$5.13 - $6.17
52-Week Range$2.43 - $10.51
Beta2.89
Analystsnone
Price Targetn/a
Earnings Daten/a
No price history available.

About IBO

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc.

Address
1400 Broadfield Blvd., Houston, TX, 77084, United States
Market Cap
53 million
Employees
2
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$147.55K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

$IBO stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in IBO holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by IBO's directors and management

Net Shares Purchased by Insiders−100k−50k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

IBO Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New IBO patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to IBO from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from IBO’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
100% of score
0
Analyst Ratings
No data yet
—
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
8
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

+0.0 since Sep 25
0255075100Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 44.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Sep 25Sep 29Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.